http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14586435

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Review
endingPage 2234
issn 1179-1950
0012-6667
issueIdentifier 20
pageRange 2215-2234
publicationName Drugs
startingPage 2215
bibliographicCitation Dando T, Plosker G. Adefovir dipivoxil: a review of its use in chronic hepatitis B. Drugs. 2003;63(20):2215–34. doi: 10.2165/00003495-200363200-00007. PMID: 14498759.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b74d5b75f55d52daa29c792ed6be4b11
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8588bebd7f8d15d5154ba1b374e5279d
date 200310
identifier https://pubmed.ncbi.nlm.nih.gov/14498759
https://doi.org/10.2165/00003495-200363200-00007
isPartOf https://portal.issn.org/resource/ISSN/0012-6667
https://portal.issn.org/resource/ISSN/1179-1950
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Adefovir dipivoxil: a review of its use in chronic hepatitis B
discusses http://id.nlm.nih.gov/mesh/M0278180
http://id.nlm.nih.gov/mesh/M0001518
http://id.nlm.nih.gov/mesh/M0000347
http://id.nlm.nih.gov/mesh/M0571031
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10923
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60172
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129613204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127945305

Total number of triples: 39.